Trial Profile
Clinical Trials Insight: 700049218
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2009
Price :
$35
*
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 26 Sep 2009 New trial record.